Development of specification for substance 7-azepan-1- il-1-ethil-6-ftor-3- (4-phenyl-1, 3-tiazol-2-il) - Quinoline- 4 (1h)-one
| dc.contributor.author | Spyrydonova, N. | |
| dc.contributor.author | Silin, A. | |
| dc.contributor.author | Lebedynets, Vyacheslav | |
| dc.contributor.author | Zavada, O. | |
| dc.contributor.author | Kalinenko, Olga | |
| dc.date.accessioned | 2019-05-06T09:29:57Z | |
| dc.date.available | 2019-05-06T09:29:57Z | |
| dc.date.issued | 2019-05 | |
| dc.description.abstract | The paper presents the results of the development of specifications for a new first-synthesized chemical compound exhibiting antibacterial activity and positioned as a perspective drug substance. According to the recommendations of the European Pharmacopoeia quality control procedures have been developed for standardization the substance of 7-azepan-1-yl-1-ethyl-6-fluoro-3-(4-phenyl-1,3-thiazol-2-yl))- quinoline-4(1H)-one - a modified derivative of the fluoroquinolone series. | ru_RU |
| dc.identifier.citation | Development of specification for substance 7-azepan-1- il-1-ethil-6-ftor-3- (4-phenyl-1, 3-tiazol-2-il) - Quinoline- 4 (1h)-one / N. V. Spyrydonova, A. V. Silin, V. A. Lebedynets, O. A. Zavada, O. S. Kalinenko // The Pharma Innovation Journal. – 2019. – V. 8 (5). – P. 54–56. | ru_RU |
| dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/22757 | |
| dc.language.iso | en | ru_RU |
| dc.subject | quality control method | ru_RU |
| dc.subject | specification | ru_RU |
| dc.subject | active pharmaceutical ingredient | ru_RU |
| dc.subject | quinolone | ru_RU |
| dc.subject | antibacterial agent | ru_RU |
| dc.title | Development of specification for substance 7-azepan-1- il-1-ethil-6-ftor-3- (4-phenyl-1, 3-tiazol-2-il) - Quinoline- 4 (1h)-one | ru_RU |
| dc.type | Article | ru_RU |